375 related articles for article (PubMed ID: 23644654)
21. Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemia.
Khandros E; Thom CS; D'Souza J; Weiss MJ
Blood; 2012 May; 119(22):5265-75. PubMed ID: 22427201
[TBL] [Abstract][Full Text] [Related]
22. Bortezomib induces apoptosis and autophagy in osteosarcoma cells through mitogen-activated protein kinase pathway in vitro.
Lou Z; Ren T; Peng X; Sun Y; Jiao G; Lu Q; Zhang S; Lu X; Guo W
J Int Med Res; 2013 Oct; 41(5):1505-19. PubMed ID: 23975859
[TBL] [Abstract][Full Text] [Related]
23. SIRT2 interferes with autophagy-mediated degradation of protein aggregates in neuronal cells under proteasome inhibition.
Gal J; Bang Y; Choi HJ
Neurochem Int; 2012 Dec; 61(7):992-1000. PubMed ID: 22819792
[TBL] [Abstract][Full Text] [Related]
24. Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation.
Hillert EK; Brnjic S; Zhang X; Mazurkiewicz M; Saei AA; Mofers A; Selvaraju K; Zubarev R; Linder S; D'Arcy P
Cancer Lett; 2019 Apr; 448():70-83. PubMed ID: 30768956
[TBL] [Abstract][Full Text] [Related]
25. Bortezomib blocks the catabolic process of autophagy via a cathepsin-dependent mechanism, affects endoplasmic reticulum stress and induces caspase-dependent cell death in antiestrogen-sensitive and resistant ER+ breast cancer cells.
Periyasamy-Thandavan S; Jackson WH; Samaddar JS; Erickson B; Barrett JR; Raney L; Gopal E; Ganapathy V; Hill WD; Bhalla KN; Schoenlein PV
Autophagy; 2010 Jan; 6(1):19-35. PubMed ID: 20110775
[TBL] [Abstract][Full Text] [Related]
26. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
Pei XY; Dai Y; Grant S
Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
[TBL] [Abstract][Full Text] [Related]
27. BAG3-dependent noncanonical autophagy induced by proteasome inhibition in HepG2 cells.
Liu BQ; Du ZX; Zong ZH; Li C; Li N; Zhang Q; Kong DH; Wang HQ
Autophagy; 2013 Jun; 9(6):905-16. PubMed ID: 23575457
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional upregulation of BAG3 upon proteasome inhibition.
Wang HQ; Liu HM; Zhang HY; Guan Y; Du ZX
Biochem Biophys Res Commun; 2008 Jan; 365(2):381-5. PubMed ID: 17996194
[TBL] [Abstract][Full Text] [Related]
29. BAG3 promoted starvation-induced apoptosis of thyroid cancer cells via attenuation of autophagy.
Li S; Zhang HY; Wang T; Meng X; Zong ZH; Kong DH; Wang HQ; Du ZX
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2298-307. PubMed ID: 25062457
[TBL] [Abstract][Full Text] [Related]
30. BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF protein.
Chiappetta G; Basile A; Arra C; Califano D; Pasquinelli R; Barbieri A; De Simone V; Rea D; Giudice A; Pezzullo L; De Laurenzi V; Botti G; Losito S; Conforti D; Turco MC
J Clin Endocrinol Metab; 2012 Jan; 97(1):E115-20. PubMed ID: 22072743
[TBL] [Abstract][Full Text] [Related]
31. Autophagic-lysosomal inhibition compromises ubiquitin-proteasome system performance in a p62 dependent manner in cardiomyocytes.
Tian Z; Wang C; Hu C; Tian Y; Liu J; Wang X
PLoS One; 2014; 9(6):e100715. PubMed ID: 24959866
[TBL] [Abstract][Full Text] [Related]
32. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines.
Bae SH; Ryoo HM; Kim MK; Lee KH; Sin JI; Hyun MS
Oncol Rep; 2008 Apr; 19(4):1027-32. PubMed ID: 18357392
[TBL] [Abstract][Full Text] [Related]
33. Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation.
Carew JS; Medina EC; Esquivel JA; Mahalingam D; Swords R; Kelly K; Zhang H; Huang P; Mita AC; Mita MM; Giles FJ; Nawrocki ST
J Cell Mol Med; 2010 Oct; 14(10):2448-59. PubMed ID: 19583815
[TBL] [Abstract][Full Text] [Related]
34. Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death.
Mishima Y; Santo L; Eda H; Cirstea D; Nemani N; Yee AJ; O'Donnell E; Selig MK; Quayle SN; Arastu-Kapur S; Kirk C; Boise LH; Jones SS; Raje N
Br J Haematol; 2015 May; 169(3):423-34. PubMed ID: 25709080
[TBL] [Abstract][Full Text] [Related]
35. An autophagy inhibitor enhances the inhibition of cell proliferation induced by a proteasome inhibitor in MCF-7 cells.
Yao F; Wang G; Wei W; Tu Y; Tong H; Sun S
Mol Med Rep; 2012 Jan; 5(1):84-8. PubMed ID: 21931937
[TBL] [Abstract][Full Text] [Related]
36. Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation.
Kao C; Chao A; Tsai CL; Chuang WC; Huang WP; Chen GC; Lin CY; Wang TH; Wang HS; Lai CH
Cell Death Dis; 2014 Nov; 5(11):e1510. PubMed ID: 25375375
[TBL] [Abstract][Full Text] [Related]
37. Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress‑mediated cell death in multiple myeloma cells.
Moriya S; Komatsu S; Yamasaki K; Kawai Y; Kokuba H; Hirota A; Che XF; Inazu M; Gotoh A; Hiramoto M; Miyazawa K
Int J Oncol; 2015 Feb; 46(2):474-86. PubMed ID: 25422130
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells.
Zhang X; Li W; Wang C; Leng X; Lian S; Feng J; Li J; Wang H
Mol Cell Biochem; 2014 Jan; 385(1-2):265-75. PubMed ID: 24104452
[TBL] [Abstract][Full Text] [Related]
39. Bortezomib resistance in a myeloma cell line is associated to PSMβ5 overexpression and polyploidy.
Balsas P; Galán-Malo P; Marzo I; Naval J
Leuk Res; 2012 Feb; 36(2):212-8. PubMed ID: 21978467
[TBL] [Abstract][Full Text] [Related]
40. BAG3 and friends: co-chaperones in selective autophagy during aging and disease.
Behl C
Autophagy; 2011 Jul; 7(7):795-8. PubMed ID: 21681022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
